Medicare Enrolled
Dr. Kevin Perry, MD
Urology Physician · Cary, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perry
Dr. Kevin Perry is an urology physician in Cary, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Perry performed 4,784 Medicare services across 2,304 unique beneficiaries.
Between the years covered by Open Payments, Dr. Perry received a total of $3,410 from 48 pharmaceutical and/or device companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in NC
$3,410 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,784
Medicare services
Top 18% in NC for urology physician
2,304
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~239 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,500 | $0 | $10 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
861 | $2 | $8 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
742 | $5 | $19 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
673 | $59 | $124 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
318 | $89 | $208 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
113 | $177 | $471 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
96 | $8 | $35 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
93 | $15 | $51 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
60 | $114 | $300 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
46 | $17 | $35 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
43 | $73 | $180 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
33 | $9 | $59 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $134 | $250 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $33 | $75 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
18 | $429 | $2,111 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $115 | $800 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
17 | $192 | $895 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
17 | $56 | $219 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
16 | $105 | $279 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
15 | $239 | $450 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
14 | $81 | $250 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $178 | $723 |
| Injection, garamycin, gentamicin, up to 80 mg | 13 | $2 | $5 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
12 | $309 | $1,230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
35.9% medium
63.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,410
Total received (2018-2024)
Avg $487/year across 7 years
Top 42% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,410 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$744
2023
$738
2022
$900
2021
$346
2020
$68
2019
$348
2018
$267
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$205
Janssen Biotech, Inc.
$132
Sumitomo Pharma America, Inc.
$109
ABBVIE INC.
$49
PFIZER INC.
$47
Tempus AI, Inc
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Boston Scientific Corporation
$24
Olympus America Inc.
$23
Blue Earth Diagnostics Limited
$22
Medtronic, Inc.
$21
IMMUNITYBIO, INC.
$20
Smith+Nephew, Inc.
$16
UROGEN PHARMA, INC.
$16
Top 3 companies account for 60.0% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$809
Janssen Biotech, Inc.
$306
Sumitomo Pharma America, Inc.
$208
Astellas Pharma US Inc
$159
ACCORD HEALTHCARE, INC.
$127
PROCEPT BioRobotics Corporation
$110
UROVANT SCIENCES INC
$107
Augmenix, Inc.
$89
ABBVIE INC.
$88
Boston Scientific Corporation
$87
PFIZER INC.
$75
GENZYME CORPORATION
$73
UroGen Pharma, Inc.
$68
AngioDynamics, Inc.
$66
Medtronic, Inc.
$63
Acerus Pharmaceuticals Corporation
$59
Olympus America Inc.
$56
AKRIMAX PHARMACEUTICALS, LLC
$53
Accord Healthcare, Inc.
$49
Blue Earth Diagnostics Limited
$49
Myovant Sciences Inc.
$46
Teleflex LLC
$45
TOLMAR Pharmaceuticals, Inc.
$38
ConvaTec Inc.
$37
Progenics Pharmaceuticals, Inc.
$35
Bayer HealthCare Pharmaceuticals Inc.
$35
Tempus AI, Inc
$34
Endo Pharmaceuticals Inc.
$33
Aytu BioScience, Inc
$33
Allergan, Inc.
$32
Tolmar, Inc.
$28
Antares Pharma, Inc.
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Bayer Healthcare Pharmaceuticals Inc.
$23
BOSTON SCIENTIFIC CORPORATION
$22
MEDIVATION FIELD SOLUTIONS LLC
$21
IMMUNITYBIO, INC.
$20
AstraZeneca Pharmaceuticals LP
$20
Biogen, Inc.
$20
Merck Sharp & Dohme LLC
$19
Smith+Nephew, Inc.
$16
UROGEN PHARMA, INC.
$16
Abbott Laboratories
$16
Merck Sharp & Dohme Corporation
$15
Allergan Inc.
$15
Axonics, Inc.
$14
Amgen Inc.
$12
AbbVie, Inc.
$11
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
ANKTIVA · Alinity c · AquaBeam Robotic System · Axonics · Axumin · BOTOX · CAMCEVI · CLARIA MRI QUAD CRT-D SURESCAN · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL EMBOLICS · GENERAL THERAPIES · GENTLECATH · GRAFIX PL · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LINQ II · LUPRON DEPOT · LYNPARZA · Lupron · Lynx System · MYRBETRIQ · NANOKNIFE · Natesto · Nubeqa · OES CYSTONEPHROFIBERSCOPE · ORGOVYX · POSLUMA · PROVENGE · PYLARIFY · REZUM · Rezum Generator · SPINRAZA · SpaceOAR · Stendra · TOVIAZ · UROLIFT · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
82
Per 100K population
7.1
County median income
$101,763
Nearest hospital
WAKEMED, CARY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perry is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perry experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Perry performed 1,500 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perry receive payments from pharmaceutical companies?
Yes. Dr. Perry received a total of $3,410 from 48 companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perry's costs compare to other urology physicians in Cary?
Dr. Perry's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cary
Browse urology physicians in Cary ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology